Polygenic Germline Risk of Common Haematological Traits Drives Clonal Selection on JAK2 V617F and Development of Myeloproliferative Neoplasms

被引：0

作者：

Nangalia, Jyoti ^{[1
]}

Guo, Jing ^{[1
]}

Walter, Klaudia ^{[1
]}

Quiros, Pedro ^{[2
]}

Gu, Muxin ^{[2
]}

Baxter, E. Joanna ^{[3
]}

Danesh, John ^{[4
]}

Di Angelantonio, Emanuele ^{[4
]}

Roberts, David ^{[4
]}

Guglielmelli, Paola ^{[5
,6
]}

Harrison, Claire N. ^{[7
]}

Godfrey, Anna L. ^{[8
]}

Green, Anthony R. ^{[9
]}

Vassiliou, George ^{[9
]}

Vuckovic, Dragana ^{[10
]}

Soranzo, Nicole ^{[11
,12
]}

机构：

[1] Wellcome Sanger Inst, Hinxton, England

[2] Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England

[3] Cambridge Univ Hosp NHS Fdn Trust, Dept Haematol, Cambridge, England

[4] Univ Cambridge, Natl Inst Hlth Res, Blood & Transplant Res Unit Donor Hlth & Gen, Cambridge, England

[5] AOU Careggi, Centro Ric & Innovazione Malattie Mieloproliferat, Florence, Italy

[6] Univ Florence, Dept Expt & Clin Med, Florence, Italy

[7] Guys & St Thomas NHS Fdn Trust, London, England

[8] Cambridge Univ Hosp NHS Trust, Cambridge, England

[9] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England

[10] Imperial Coll London, London, England

[11] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England

[12] Human Technopole, Milan, Italy

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-189551

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] JAK2 (V617F) mutation in patients with chronic myeloproliferative disorders
Hamidah, N.
Farisah, N.
Jalil, N.
Fei-Liang, W.
AWahid, F.
Othman, A.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 121 - 122
[42] Comparison of JAK2 V617F positive and negative myeloproliferative diseases
Szilvasi, A.
Andrikovics, H.
Meggyesi, N.
Tamaska, J.
Halm, G.
Lueff, S.
Nahajevszky, S.
Egyed, M.
Varkonyi, J.
Mikala, G.
Sipos, A.
Tordai, A.
Masszi, T.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 379 - 379
[43] Clinical characteristics of JAK2 V617F positive myeloproliferative diseases
Andrikovics, H.
Szilvasi, A.
Meggyesi, N.
Tamaska, J.
Halm, G.
Lueff, S.
Nahajevszky, S.
Egyed, M.
Varkonyi, J.
Mikala, G.
Sipos, A.
Tordai, A.
Masszi, T.
BLOOD REVIEWS, 2007, 21 : S124 - S124
[44] REAL TIME DETECTION OF JAK2 V617F IN THE MYELOPROLIFERATIVE DISORDERS
Goday-Fernandez, A.
Boyd, E. M.
Bench, A. J.
Erber, W. N.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 302 - 302
[45] JAK2 V617F ALLELE BURDEN IN CHRONIC MYELOPROLIFERATIVE DISEASES
Skerget, Matevz
Pajic, Tadej
Kralj, Eva
Vuckovic, Josko
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I57 - I61
[46] Rapid detection of JAK2 V617F mutation in myeloproliferative disorders
Mir, Rashid
AbuDuhier, Faisal M.
ANNALS OF ONCOLOGY, 2016, 27
[47] Myeloproliferative Neoplasms with Concurrent BCR-ABL1 Translocation and JAK2 V617F Mutation
Soderquist, Craig
Ewalt, Mark D.
Czuchlewski, David
Geyer, Julia
Rogers, Heesun J.
Babushok, Daria
Hexner, Elizabeth
Orazi, Attilio
Hsi, Eric D.
Wang, Sa
Bueso-Ramos, Carlos E.
Arber, Daniel A.
Bagg, Adam
LABORATORY INVESTIGATION, 2016, 96 : 377A - 377A
[48] BCR::ABL1 translocation and JAK2 V617F mutation testing in myeloproliferative neoplasms
Paro, M. M. Kardum
Svabek, Z. Tkalcic
Horvat, M.
Martinovic, M.
Smoljanovic, I. Mandac
Kolonic, S. Ostojic
Kristo, D. Radic
CLINICA CHIMICA ACTA, 2024, 558
[49] The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis
Goodyer, Matthew
Langabeer, Stephen E.
Haslam, Karl
Murphy, Karen
PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (01) : 229 - 230
[50] A Prolonged Low Level JAK2 V617F Is Significant In Clinically Suspicious Myeloproliferative Neoplasms (MPN)
Vail, E.
Chevarie-Davis, M.
Riley, C.
Lopategui, J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 957 - 958

← 1 2 3 4 5 →